Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Anemia

  Free Subscription


Articles published in Kidney Int

Retrieve available abstracts of 32 articles:
HTML format



Single Articles


    August 2022
  1. FUCHS MAA, Kurtz A
    The fate of erythropoietin-producing cells: another piece of the puzzle.
    Kidney Int. 2022;102:230-233.
    PubMed     Abstract available


    June 2022
  2. BATTE A, Menon S, Ssenkusu JM, Kiguli S, et al
    Neutrophil gelatinase-associated lipocalin is elevated in children with acute kidney injury and sickle cell anemia, and predicts mortality.
    Kidney Int. 2022 Jun 16. pii: S0085-2538(22)00453.
    PubMed     Abstract available


  3. VAN DEN BROEK B, van der Flier M, van de Kar NCAJ, Wetzels JFM, et al
    Eculizumab impairs killing of Neisseria meningitidis serogroup B in atypical hemolytic uremic syndrome patients vaccinated with MenB-4C.
    Kidney Int. 2022;101:1293-1295.
    PubMed    


  4. WAGENER FADTG, van de Kar NCAJ, van den Heuvel LP
    Protective mechanisms harnessing against injurious heme and preventing kidney damage in STEC-HUS: toward new therapies?
    Kidney Int. 2022;101:1107-1109.
    PubMed     Abstract available


  5. PIRSCHEL W, Mestekemper AN, Wissuwa B, Krieg N, et al
    Divergent roles of haptoglobin and hemopexin deficiency for disease progression of Shiga-toxin-induced hemolytic-uremic syndrome in mice.
    Kidney Int. 2022;101:1171-1185.
    PubMed     Abstract available


    May 2022
  6. KANEKO K, Sato Y, Uchino E, Toriu N, et al
    Lineage tracing analysis defines erythropoietin-producing cells as a distinct subpopulation of resident fibroblasts with unique behaviors.
    Kidney Int. 2022 May 26. pii: S0085-2538(22)00376.
    PubMed     Abstract available


  7. LABES R, Brinkmann L, Kulow VA, Roegner K, et al
    Daprodustat prevents Cyclosporine-A mediated anemia and peritubular capillary loss.
    Kidney Int. 2022 May 25. pii: S0085-2538(22)00375.
    PubMed     Abstract available


    April 2022
  8. HANUDEL MR, Czaya B, Wong S, Rappaport M, et al
    Enteral ferric citrate absorption is dependent on the iron transport protein ferroportin.
    Kidney Int. 2022;101:711-719.
    PubMed     Abstract available


  9. HAASE VH
    The ins and outs of ferric citrate.
    Kidney Int. 2022;101:668-670.
    PubMed     Abstract available


    March 2022
  10. JOLES JA
    Anemia and red blood cell deformability in proteinuric chronic kidney disease.
    Kidney Int. 2022;101:649.
    PubMed    


    December 2021
  11. DRUEKE TB, Massy ZA
    Role of proteinuria in the anemia of chronic kidney disease.
    Kidney Int. 2021;100:1160-1162.
    PubMed     Abstract available


    September 2021
  12. BISSINGER R, Nemkov T, D Alessandro A, Grau M, et al
    Proteinuric chronic kidney disease is associated with altered red blood cell lifespan, deformability and metabolism.
    Kidney Int. 2021 Sep 16. pii: S0085-2538(21)00858.
    PubMed     Abstract available


    August 2021
  13. LILL JK, Thiebes S, Pohl JM, Bottek J, et al
    Tissue-resident macrophages mediate neutrophil recruitment and kidney injury in shiga toxin-induced hemolytic uremic syndrome.
    Kidney Int. 2021;100:349-363.
    PubMed     Abstract available


  14. BOUWMEESTER RN, van de Kar NCAJ, Wetzels JFM
    Enough is enough: targeted eculizumab withdrawal in atypical hemolytic uremic syndrome.
    Kidney Int. 2021;100:265-268.
    PubMed    


    July 2021
  15. SCIESIELSKI LK, Felten M, Michalick L, Kirschner KM, et al
    The circadian clock regulates rhythmic erythropoietin expression in the murine kidney.
    Kidney Int. 2021 Jul 29. pii: S0085-2538(21)00729.
    PubMed     Abstract available


  16. IKEDA Y
    Novel roles of HIF-PHIs in chronic kidney disease: the link between iron metabolism, kidney function, and FGF23.
    Kidney Int. 2021;100:14-16.
    PubMed     Abstract available


  17. ARICETA G, Dixon BP, Kim SH, Kapur G, et al
    The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naive to complement inhibitor treatment.
    Kidney Int. 2021;100:225-237.
    PubMed     Abstract available


    June 2021
  18. KOYUN M, Kaya Aksoy G, Comak E, Ozaltin F, et al
    Outcome of diacylglycerol kinase epsilon-mediated hemolytic uremic syndrome in an infant.
    Kidney Int. 2021;99:1500-1501.
    PubMed    


    April 2021
  19. BABITT JL, Eisenga MF, Haase VH, Kshirsagar AV, et al
    Controversies in Optimal Anemia Management: Conclusions from a Kidney Disease Improving Global Outcomes (KDIGO) Conference.
    Kidney Int. 2021 Apr 8. pii: S0085-2538(21)00355.
    PubMed     Abstract available


    March 2021
  20. HANUDEL MR, Wong S, Jung G, Qiao B, et al
    Amelioration of chronic kidney disease-associated anemia by vadadustat in mice is not dependent on erythroferrone.
    Kidney Int. 2021 Mar 31. pii: S0085-2538(21)00354.
    PubMed     Abstract available


  21. FUCHS MAA, Broeker KAE, Schrankl J, Burzlaff N, et al
    Inhibition of transforming growth factor beta1 signaling in resident interstitial cells attenuates profibrotic gene expression and preserves erythropoietin production during experimental kidney fibrosis in mice.
    Kidney Int. 2021 Mar 8. pii: S0085-2538(21)00278.
    PubMed     Abstract available


    January 2021
  22. VILLE S, Le Bot S, Chapelet-Debout A, Blancho G, et al
    Atypical HUS relapse triggered by COVID-19.
    Kidney Int. 2021;99:267-268.
    PubMed    


    November 2020
  23. NORIS M, Remuzzi G
    Atypical hemolytic uremic syndrome associated with a factor B genetic variant and fluid-phase complement activation: an exception to the rule?
    Kidney Int. 2020;98:1084-1087.
    PubMed     Abstract available


  24. HASSANEIN M, Liaqat A, Paratore DA, Vachharajani TJ, et al
    The Case | Arrhythmias in a patient with sickle cell disease on hemodialysis.
    Kidney Int. 2020;98:1357-1358.
    PubMed    


    May 2020
  25. BROEKER KAE, Fuchs MAA, Schrankl J, Kurt B, et al
    Different subpopulations of kidney interstitial cells produce erythropoietin and factors supporting tissue oxygenation in response to hypoxia in vivo.
    Kidney Int. 2020 May 23. pii: S0085-2538(20)30542.
    PubMed     Abstract available


    April 2020
  26. WYATT CM, Drueke TB
    Inhibition of HIF prolyl-hydroxylase domain to correct anemia in patients with chronic kidney disease.
    Kidney Int. 2020;97:639-642.
    PubMed    


    December 2019
  27. HANUDEL MR
    Ferric citrate: cardio- and renoprotective in chronic kidney disease?
    Kidney Int. 2019;96:1277-1279.
    PubMed     Abstract available


    November 2019
  28. EL KAROUI K, Boudhabhay I, Fremeaux-Bacchi V
    Atypical hemolytic uremic syndrome and hypertensive crisis.
    Kidney Int. 2019;96:1239.
    PubMed    


    May 2019
  29. CAVERO T, Arjona E, Soto K, Caravaca-Fontan F, et al
    Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome.
    Kidney Int. 2019 May 31. pii: S0085-2538(19)30582.
    PubMed     Abstract available


  30. CHO ME, Hansen JL, Peters CB, Cheung AK, et al
    An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic Veterans with predialysis chronic kidney disease.
    Kidney Int. 2019 May 15. pii: S0085-2538(19)30506.
    PubMed     Abstract available


    April 2019
  31. DUINEVELD C, Wijnsma KL, Volokhina EB, van den Heuvel LPB, et al
    Placental passage of eculizumab and complement blockade in a newborn.
    Kidney Int. 2019;95:996.
    PubMed    


    February 2019
  32. IMERI F, Nolan KA, Bapst AM, Santambrogio S, et al
    Generation of renal Epo-producing cell lines by conditional gene tagging reveals rapid HIF-2 driven Epo kinetics, cell autonomous feedback regulation, and a telocyte phenotype.
    Kidney Int. 2019;95:375-387.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: